Elon Musk recently claimed he could cut at least $2 trillion from the US Federal budget—a challenge that would require unprecedented austerity measures. This ambitious target surpasses annual spending ...
KR Choksey recommended accumulate rating on Sun Pharmaceutical Industries with a target price of Rs 1967 in its research report dated October 30, 2024.